Kenvue INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Kenvue Inc. reported a 2.1% decline in net sales for fiscal year 2025, alongside a 42.7% increase in net income driven by lower impairment charges, as it progresses towards a merger with Kimberly-Clark Corporation.
NYSE
Kenvue Inc. details its financial performance for fiscal year 2024, highlighting its ongoing separation from J&J, restructuring initiatives, and strategic focus on consumer health.
NYSE
Kenvue Inc.'s recent SEC filing outlines the company's common and preferred stock structure, voting rights, dividend policies, and measures designed to deter hostile takeovers.